Viewing Study NCT06388135


Ignite Creation Date: 2025-12-24 @ 10:40 PM
Ignite Modification Date: 2026-06-15 @ 8:15 PM
Study NCT ID: NCT06388135
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-04-29
First Post: 2024-04-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Serplulimab Combined With Nab-paclitaxel and Cisplatin in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma
Sponsor: Yang Jianjun, PhD
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Esophageal Squamous Cell Carcinoma View
Keywords: